51
Participants
Start Date
August 31, 2015
Primary Completion Date
June 30, 2016
Study Completion Date
January 30, 2021
300 mg SC
Salacia (T1) capsule given with breakfast (mixed meal tolerance test)
500 mg SC
Salacia (T2) capsule given with breakfast (mixed meal tolerance test)
Placebo
Placebo capsule given with breakfast (mixed meal tolerance test)
Rutgers University, New Brunswick
Collaborators (1)
OmniActive Health Technologies
INDUSTRY
Rutgers University
OTHER